JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB62344

Anti-RIP3 antibody

5

(5 Reviews)

|

(77 Publications)

Rabbit Polyclonal RIP3 antibody. Suitable for WB, IHC-P and reacts with Mouse, Rat samples. Cited in 77 publications. Immunogen corresponding to Synthetic Peptide within Mouse Ripk3.

View Alternative Names

Rip3, Ripk3, Receptor-interacting serine/threonine-protein kinase 3, RIP-like protein kinase 3, Receptor-interacting protein 3, RIP-3, mRIP3

4 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RIP3 antibody (AB62344)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RIP3 antibody (AB62344)

Immunohistochemical analysis of paraffin-embedded mouse thymus tissue using anti-RIP3 antibody (ab62344) at 1 µg/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4°C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.

Western blot - Anti-RIP3 antibody (AB62344)
  • WB

Supplier Data

Western blot - Anti-RIP3 antibody (AB62344)

Primary antibody incubation : 1h incubation at Room Temperature in 5% NFDM/TBST.

Lanes 1 - 2:

Western blot - Anti-RIP3 antibody (ab62344) at 0.1 µg/mL

Lane 3:

Western blot - Anti-RIP3 antibody (ab62344) at 0.2 µg/mL

Lane 4:

Western blot - Anti-RIP3 antibody (ab62344) at 0.5 µg/mL

Lane 1:

C2C12 (mouse myoblast cell line) cell lysate at 15 µg with Peptide blocking

Lanes 2 - 4:

C2C12 (mouse myoblast cell line) cell lysate at 15 µg

Secondary

All lanes:

Goat anti-rabbit IgG HRP conjugate at 1/10000 dilution

Predicted band size: 57 kDa

false

Western blot - Anti-RIP3 antibody (AB62344)
  • WB

Supplier Data

Western blot - Anti-RIP3 antibody (AB62344)

1h incubation at RT in 5% NFDM/TBST

All lanes:

Western blot - Anti-RIP3 antibody (ab62344) at 0.5 µg/mL

All lanes:

Rat thymus tissue lysates at 15 µg

Secondary

All lanes:

Goat anti-rabbit IgG HRP conjugate at 1/10000 dilution

Predicted band size: 57 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RIP3 antibody (AB62344)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RIP3 antibody (AB62344)

Immunohistochemical analysis of paraffin-embedded mouse kidney tissue with ab62344 at 2.5 μg/mL. Sections were fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH 6.0). Samples were incubated with primary antibody overnight at 4˚C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat

Applications

IHC-P, WB

applications

Immunogen

Synthetic Peptide within Mouse Ripk3. The exact immunogen used to generate this antibody is proprietary information.

Q9QZL0

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.1-0.5 µg/mL", "WB-species-notes": "<p>Primary antibody incubation: 1h incubation at Room Temperature in 5% NFDM/TBST.</p><p><strong>Observed: 53kD for mouse RIP3</strong></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1-5 µg/mL", "IHCP-species-notes": "<p></p>" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.1-0.5 µg/mL", "WB-species-notes": "<p>Primary antibody incubation: 1h incubation at Room Temperature in 5% NFDM/TBST.</p><p><strong>Observed: 53kD for mouse RIP3</strong></p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.2 Preservative: 0.02% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

'Receptor-interacting protein kinase 3' (RIP3) also known as RIPK3 is a serine/threonine-protein kinase with a molecular weight of approximately 57 kDa. Mechanically it contains a kinase domain that allows it to phosphorylate specific substrates which is important for mediating its function within the cell. RIP3 is expressed in various tissues with notable presence in the spleen heart and adipose tissue. The protein localizes predominantly in the cytoplasm where it interacts with other cellular proteins to initiate downstream signaling events.
Biological function summary

RIP3 facilitates the execution of necroptosis a form of programmed cell death distinct from apoptosis. It becomes activated upon binding with RIP1 forming a necrosome complex that is essential for this pathway. This complex promotes phosphorylation events that subsequently lead to membrane rupture and cell death. Apart from its role in necroptosis RIP3 also engages in metabolic regulation processes linking energy status and cell death under conditions of stress.

Pathways

RIP3 is a principal component of the necroptotic pathway interacting closely with RIP1 to trigger cell death in conditions where caspase activation is inhibited. Alternatively it integrates into metabolic pathways participating in sensing and responding to changes in cellular energy states. The interplay between RIP3 and RIP1 within these pathways illustrates their shared involvement in maintaining cellular homeostasis and triggering cell death when necessary.

RIP3 has significant implications for conditions involving excessive or dysfunctional cell death such as inflammatory diseases and reperfusion injury. The necroptotic activity of RIP3 can exacerbate inflammation by promoting the release of pro-inflammatory factors upon cell death. Furthermore during ischemia-reperfusion injury increased RIP3 activity in conjunction with MLKL another necroptosis-associated protein contributes to tissue damage highlighting its potential as a therapeutic target for reducing cell death-related tissue damage.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Serine/threonine-protein kinase that activates necroptosis and apoptosis, two parallel forms of cell death (PubMed : 27321907, PubMed : 27746097, PubMed : 27917412, PubMed : 28607035, PubMed : 32200799, PubMed : 32296175). Necroptosis, a programmed cell death process in response to death-inducing TNF-alpha family members, is triggered by RIPK3 following activation by ZBP1 (PubMed : 19590578, PubMed : 22423968, PubMed : 24012422, PubMed : 24019532, PubMed : 24095729, PubMed : 24557836, PubMed : 27321907, PubMed : 27746097, PubMed : 27819681, PubMed : 27819682, PubMed : 32200799, PubMed : 32296175). Activated RIPK3 forms a necrosis-inducing complex and mediates phosphorylation of MLKL, promoting MLKL localization to the plasma membrane and execution of programmed necrosis characterized by calcium influx and plasma membrane damage (PubMed : 24813849, PubMed : 24813850, PubMed : 27321907). In addition to TNF-induced necroptosis, necroptosis can also take place in the nucleus in response to orthomyxoviruses infection : following ZBP1 activation, which senses double-stranded Z-RNA structures, nuclear RIPK3 catalyzes phosphorylation and activation of MLKL, promoting disruption of the nuclear envelope and leakage of cellular DNA into the cytosol (PubMed : 32200799, PubMed : 32296175). Also regulates apoptosis : apoptosis depends on RIPK1, FADD and CASP8, and is independent of MLKL and RIPK3 kinase activity (PubMed : 27321907). Phosphorylates RIPK1 : RIPK1 and RIPK3 undergo reciprocal auto- and trans-phosphorylation (By similarity). In some cell types, also able to restrict viral replication by promoting cell death-independent responses (PubMed : 30635240). In response to flavivirus infection in neurons, promotes a cell death-independent pathway that restricts viral replication : together with ZBP1, promotes a death-independent transcriptional program that modifies the cellular metabolism via up-regulation expression of the enzyme ACOD1/IRG1 and production of the metabolite itaconate (PubMed : 30635240). Itaconate inhibits the activity of succinate dehydrogenase, generating a metabolic state in neurons that suppresses replication of viral genomes (PubMed : 30635240). RIPK3 binds to and enhances the activity of three metabolic enzymes : GLUL, GLUD1, and PYGL (By similarity). These metabolic enzymes may eventually stimulate the tricarboxylic acid cycle and oxidative phosphorylation, which could result in enhanced ROS production (By similarity).
See full target information Ripk3

Publications (77)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 16:4288 PubMed40341069

2025

Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro.

Applications

Unspecified application

Species

Unspecified reactive species

Haixia Su,Guofeng Chen,Hang Xie,Wanchen Li,Muya Xiong,Jian He,Hangchen Hu,Wenfeng Zhao,Qiang Shao,Minjun Li,Qiang Zhao,Yechun Xu

Frontiers in immunology 16:1513637 PubMed40264785

2025

Macrophage caspase-8 inhibition accelerates necrotic core expansion in atheroma plaque in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Thomas Pilot,Stéphanie Solier,Antoine Jalil,Charlène Magnani,Tom Vanden Berghe,Peter Vandenabeele,David Masson,Eric Solary,Charles Thomas

Cell death & disease 16:283 PubMed40221396

2025

Gasdermin D deficiency aggravates nephrocalcinosis-related chronic kidney disease with rendering macrophages vulnerable to necroptosis.

Applications

Unspecified application

Species

Unspecified reactive species

Yoshihiro Kusunoki,Chenyu Li,Hao Long,Kanako Watanabe-Kusunoki,Meisi Kuang,Julian Aurelio Marschner,Andreas Linkermann,Stefanie Steiger,Hans-Joachim Anders

Communications biology 8:573 PubMed40188179

2025

Targeting alveolar epithelial cells with lipid micelle-encapsulated necroptosis inhibitors to alleviate acute lung injury.

Applications

Unspecified application

Species

Unspecified reactive species

Zhi-Ying Kang,Nan-Xia Xuan,Qi-Chao Zhou,Qian-Yu Huang,Meng-Jia Yu,Gen-Sheng Zhang,Wei Cui,Zhao-Cai Zhang,Yang Du,Bao-Ping Tian

Chinese medical journal pulmonary and critical care medicine 2:265-278 PubMed39834583

2025

Parkin deficiency aggravates inflammation-induced acute lung injury by promoting necroptosis in alveolar type II cells.

Applications

Unspecified application

Species

Unspecified reactive species

Meiyu Quan,Qiang Guo,Xihua Yan,Chenhua Yu,Linglong Yang,Yuting Zhang,Jiaqi Li,Qiongxia Weng,Bin Liu,Quan Li,Li Dong,Junjie Chen,Zhenkun Lou,Xuru Jin,Chengshui Chen,Jin-San Zhang

International journal of biological sciences 20:4713-4730 PubMed39309425

2024

Neutrophil extracellular traps trigger alveolar epithelial cell necroptosis through the cGAS-STING pathway during acute lung injury in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Han-Xi Sha,Yu-Biao Liu,Yan-Ling Qiu,Wen-Jing Zhong,Nan-Shi-Yu Yang,Chen-Yu Zhang,Jia-Xi Duan,Jian-Bing Xiong,Cha-Xiang Guan,Yong Zhou

Cell regeneration (London, England) 13:14 PubMed39093347

2024

METTL3 restricts RIPK1-dependent cell death via the ATF3-cFLIP axis in the intestinal epithelium.

Applications

Unspecified application

Species

Unspecified reactive species

Meimei Huang,Xiaodan Wang,Mengxian Zhang,Yuan Liu,Ye-Guang Chen

Antioxidants (Basel, Switzerland) 13: PubMed39061874

2024

Apomorphine Suppresses the Progression of Steatohepatitis by Inhibiting Ferroptosis.

Applications

Unspecified application

Species

Unspecified reactive species

Hiroshi Maeda,Kouichi Miura,Kenichi Aizawa,Oyunjargal Bat-Erdene,Miho Sashikawa-Kimura,Eri Noguchi,Masako Watanabe,Naoya Yamada,Hitoshi Osaka,Naoki Morimoto,Hironori Yamamoto

International journal of molecular sciences 25: PubMed38674016

2024

The CaMK Family Differentially Promotes Necroptosis and Mouse Cardiac Graft Injury and Rejection.

Applications

Unspecified application

Species

Unspecified reactive species

Haitao Lu,Jifu Jiang,Jeffery Min,Xuyan Huang,Patrick McLeod,Weihua Liu,Aaron Haig,Lakshman Gunaratnam,Anthony M Jevnikar,Zhu-Xu Zhang

Cell death and differentiation 31:672-682 PubMed38548850

2024

ZBP1 and TRIF trigger lethal necroptosis in mice lacking caspase-8 and TNFR1.

Applications

Unspecified application

Species

Unspecified reactive species

Margaret Solon,Nianfeng Ge,Shannon Hambro,Susan Haller,Jian Jiang,Miriam Baca,Jessica Preston,Allie Maltzman,Katherine E Wickliffe,Yuxin Liang,Rohit Reja,Dorothee Nickles,Kim Newton,Joshua D Webster
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com